The latest price and medical insurance reimbursement status of Selinexor in 2025
Selinesol is an oral selective nuclear export inhibitor (SINE), mainly used for the treatment of multiple myeloma and other hematological tumors. The drug is currently on the market in China and has been included in my country's medical insurance system. Eligible patients can purchase it in hospital pharmacies and enjoy medical insurance reimbursement. The inclusion of medical insurance provides financial support to patients and makes long-term medication more sustainable. However, the specific reimbursement ratio and policy vary from region to region, and patients need to consult the local hospital pharmacy for confirmation.
In the domestic market, the price of the original Seleniso drug ranges from RMB 5,000 to RMB 10,000. The price range is mainly affected by drug specifications, hospital procurement channels and local medical insurance policies. When patients use this drug, they can reasonably arrange treatment plans based on medical insurance reimbursement policies, thereby reducing the financial pressure on medication while ensuring the continued supply and efficacy of the drug.
Generic drugs of Seleniso also exist in overseas markets, and the price is relatively cheaper. They are mainly Lao version of generic drugs, and the price per box is about more than 2,000 yuan. Although the price is low, generic drugs are basically the same as domestic original drugs in terms of ingredients and similar efficacy. However, when purchasing overseas generic drugs, patients should choose formal and legal channels to ensure drug quality and medication safety, and follow the doctor's medication instructions.
In general, the medical insurance coverage of seliniso provides stable medication protection for domestic patients, allowing more patients to afford targeted therapy. Regardless of whether they choose domestic original drugs or overseas generic drugs, patients should use them under the guidance of a doctor, regularly follow up and monitor blood, liver and kidney functions to ensure maximum efficacy, control adverse reactions, and achieve safe and effective long-term treatment.
Reference link:https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)